The Michael J. Fox Foundation
Grand Central Station
P.O. Box 4777
216 articles with The Michael J. Fox Foundation
Highlights: Michael J. Fox Foundation grants Alterity $US495K for Parkinson's disease research evaluation Strengthening profile at investment, scientific and clinical conferences Dr David Stamler appointed Chief Executive Officer Cash balance as at 31 March 2021 of A$32.8M
Michael J. Fox Foundation Honors William Dauer, MD, with Bachmann-Strauss Prize for Excellence in Dystonia Research
The Michael J. Fox Foundation for Parkinson's Research (MJFF) has announced William Dauer , MD, director of the Peter O'Donnell Jr. Brain Institute and professor of neurology and neuroscience at the University of Texas Southwestern Medical Center in Dallas , as the recipient of the sixth annual Bachmann-Strauss Prize for Excellence i
Michael J. Fox Foundation Honors Caroline Tanner, MD, PhD, with Robert A. Pritzker Prize for Leadership in Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research (MJFF) has awarded the 2020 Robert A. Pritzker Prize for Leadership in Parkinson's Research to Caroline Tanner , MD, PhD, professor of neurology at the Weill Institute for Neurosciences, University of California, San Francisco . The Prize recognizes researchers who make exceptio
Amydis Awarded Michael J. Fox Foundation Grant to Accelerate Development of an Alpha-Synuclein Retinal Tracer to Diagnose Parkinson’s Disease Through the Eye
Amydis, Inc., a biotechnology company developing a new class of diagnostics to enable the early detection of neurological diseases through the retina, today announced that it has received a new grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) for the Company’s pioneering retinal tracer program for alpha-synuclein (ASYN). Amydis received previous grant support from MJFF in 2018 to evaluate its patent-protected portfolio of n
CytRx Corporation Highlights Orphazyme's Announcement of its Collaboration with The Michael J. Fox Foundation on Parkinson's Disease Research
CytRx Corporation (OTCQB: CYTR), a biopharmaceutical research and development company specializing principally in oncology and neurodegenerative diseases, today highlighted that
Funding will advance study to quantify protein-based biomarker for the disease
The Michael J. Fox Foundation Releases New Video Resource to Empower Patients and Families to Participate in Critical Parkinson's Research
- New animated video, "Together, We Can Solve the Parkinson's Puzzle," aims to encourage Parkinson's patients and families to take part in research to help speed a cure - Narrated by Emmy- and Golden Globe-winning actor Alan Alda, the video can be watched at michaeljfox.org/your-role-research - Content made possible by ACADIA Pharmaceuticals, with additional funding from members of MJFF's Parkinson's Disease Education Consortium
2/28/2020Biopharma and life sciences strengthen their executive leadership teams and boards with this week's Movers & Shakers.
The Michael J. Fox Foundation for Parkinson's Research Announces New Chairman of the Board, Biopharma Leader Skip Irving
The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced the appointment of Skip Irving as chairman of its Board of Directors.
The Michael J. Fox Foundation's Edmond J. Safra Fellowship in Movement Disorders Selects Class of 2022
Five physicians chosen to receive movement disorders clinical and research training at top-tier international academic centers
Honda R&D Americas Collaborates With The Ohio State University and The Michael J. Fox Foundation to Research Walking Assist Device Efficacy in People with Parkinson's Disease
Actor's foundation awards grant to conduct clinical trial
Every year, Forbes creates a list of 30 Under 30, people under the age of 30 who have made a mark and show promise in various areas. They just came out with the 2019 30 Under 30: Healthcare. Here we highlight a dozen of the winners for their roles in biopharma-related endeavors.
Michael J. Fox Foundation Announces Availability of $7.5 Million in Spring 2019 Funding to Further Research in Parkinson's Disease Biology, Biomarkers and Therapies
Applications due September 26, 2018
The Michael J. Fox Foundation for Parkinson's Research Announces Availability of $7 Million in Fall 2018 Research Funding to Expand Understanding of Parkinson's Disease and Accelerate Drug Development
- Funding programs aim to support Parkinson's research into gait and balance disturbances, leading drug targets and biological markers - Programs prioritize unmet patient needs and most promising areas of scientific discovery
Sage Bionetworks in Collaboration with The Michael J. Fox Foundation Announce Winners in the DREAM Parkinson’s Disease Digital Biomarker Challenge
Sage Bionetworks announced today the results of the Parkinson’s Disease Digital Biomarker (PDDM) DREAM challenge, an open crowd-sourced research project designed to benchmark the use of remote sensors to diagnose and track Parkinson’s disease (PD).
The Michael J. Fox Foundation Release: Protein Levels in Spinal Fluid Correlate to Posture and Gait Difficulty in Parkinson's Disease
This analysis points to associations that could inform subject selection for clinical trials, speeding testing of symptomatic and disease-modifying therapies.
Biden Cancer Initiative, Michael J. Fox Foundation for Parkinson's Research, Novartis and Others Support Bridging Clinical Research & Clinical Health Care Collaborative
The event, which has three focus areas — regulatory, technology, and people and processes — will feature many prominent speakers.
Horizon Discovery Partners With the Michael J. Fox Foundation to Introduce Novel Pre-Clinical Models for Parkinson's Disease
Horizon Discovery introduced two new gene knock-out and knock-in rat models for investigating the role of alpha-synuclein in brain function and Parkinson's disease (PD) pathogenesis.
Mitochon Pharma Awarded Grant From The Michael J. Fox Foundation To Support Mitochondrial Research In Parkinson’s
The Michael J. Fox Foundation Launches Clinician Input Study In Parkinson's Disease To Evaluate Mobile Technology In Clinical Care